During the past decade, Michele Barone conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Michele Barone" are "Antibiotic Resistant Infection" (1 trials), "Antibiotic Resistant Strain" (1 trials), "C-Reactive Protein" (1 trials), "Helicobacter Pylori Infection" (1 trials) and "Inflammatory Bowel Diseases" (1 trials). Many other conditions were trialed in "Michele Barone" in a lesser frequency.

Most popular intervention types in "Michele Barone" are "Dietary Supplement" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amoxicillin 1000 MG" (1 trials), "Bismuth Subcitrate" (1 trials), "Clarithromycin 500mg" (1 trials), "Diet containing placebo" (1 trials) and "Levofloxacin 500mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Michele Barone" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Michele Barone". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Michele Barone, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Michele Barone, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".